{"id":22572,"date":"2023-01-10T11:33:41","date_gmt":"2023-01-10T10:33:41","guid":{"rendered":"https:\/\/idibell.cat\/en\/?p=22572"},"modified":"2023-04-27T11:41:45","modified_gmt":"2023-04-27T09:41:45","slug":"idibell-receives-1-2-million-euros-in-grants-to-promote-scientific-research-and-its-transfer","status":"publish","type":"post","link":"https:\/\/idibell.cat\/en\/2023\/01\/idibell-receives-1-2-million-euros-in-grants-to-promote-scientific-research-and-its-transfer\/","title":{"rendered":"IDIBELL receives 1.2 million euros in grants to promote scientific research and its transfer"},"content":{"rendered":"<p>On December 23, it was announced that IDIBELL was the recipient of five grants in the call for the state program for scientific and technical research. The purpose of these grants is to promote collaborative projects between public and private institutions for the transfer of knowledge and innovation in health, and are part of the state plan for scientific, technical and innovation research 2021-2023, within the framework of the recovery plan, transformation and resilience, from the Ministry of Economic Affairs and Digital Transformation (MINECO).<\/p>\n<p>&nbsp;<\/p>\n<p>Among the projects financed, the one for precision radiotherapy for breast cancer stands out, or both clinical trials to evaluate the effects of the administration of ApTOLL in patients with stroke and myocardial infarction. On the other hand, other projects financed seek new approaches for the diagnosis of endometrial cancer and the search for therapies for Ewing&#8217;s sarcoma.<\/p>\n<p>&nbsp;<\/p>\n<p>In total, the five projects will receive funding of more than 1.2 million for scientific research and innovation in health. IDIBELL celebrates this news as a fundamental impulse for its commitment to the health and well-being of society.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Project list:<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Reference: CPP2021-008368<br \/>\nTitle: radioterapia de precisi\u00f3n: firma molecular predictiva para radiosensibilidad en c\u00e1ncer de mama<br \/>\nPrincipal Investigator: Ferran Guedea<br \/>\nFunded: 110.013,00 \u20ac<\/p>\n<p>&nbsp;<\/p>\n<p>Reference: CPP2021-008378<br \/>\nTitle: Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL<br \/>\nPrincipal Investigator: Pere Cardona Portela<br \/>\nFunded: 487.992,80 \u20ac<\/p>\n<p>&nbsp;<\/p>\n<p>Reference: CPP2021-008379<br \/>\nTitle: Clinical trial to evaluate the administration of ApTOLL in Acute Myocardial Infarction. APSTEMI<br \/>\nPrincipal Investigator: Joan Antoni Gomez Hospital<br \/>\nFunded: 259.100,89 \u20ac<\/p>\n<p>&nbsp;<\/p>\n<p>Reference: CPP2021-008440<br \/>\nTitle: Womec advanced: nuevas aproximaciones para el diagn\u00f3stico de c\u00e1ncer de endometrio<br \/>\nPrincipal Investigator: Laura Costas Caudet<br \/>\nFunded: 194.288,00 \u20ac<\/p>\n<p>&nbsp;<\/p>\n<p>Reference: CPP2021-008515<br \/>\nTitle: traslaci\u00f3n a la cl\u00ednica de una nueva terapia dirigida para el tratamiento del sarcoma de ewing<br \/>\nPrincipal Investigator: Oscar Mart\u00ednez Tirado<br \/>\nFunded: 199.904,74 \u20ac<\/p>\n<p>&nbsp;<\/p>\n<p>Funded by MCIN\/AEI\/10.13039\/501100011033 and by the European Union-NextGenerationEU\/PRT<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-full wp-image-22576\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/01\/thumbnail_image005.png\" alt=\"\" width=\"734\" height=\"124\" srcset=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/01\/thumbnail_image005.png 734w, https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2023\/01\/thumbnail_image005-300x51.png 300w\" sizes=\"(max-width: 734px) 100vw, 734px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Funded projects address different areas of health, from precision radiotherapy to the search for therapies for breast cancer and other diseases.<\/p>\n","protected":false},"author":8,"featured_media":22573,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[206,185,239,220,237],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-10 16:33:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/22572"}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=22572"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/22572\/revisions"}],"predecessor-version":[{"id":22577,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/posts\/22572\/revisions\/22577"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media\/22573"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=22572"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/categories?post=22572"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/tags?post=22572"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}